Cubosome dispersions as delivery systems for percutaneous administration of indomethacin

Pharmaceutical Research

Volumn 22, Issue 12, 2005, Pages 2163-2173

  Esposito, Elisabetta ^a   Cortesi, Rita ^a   Drechsler, Markus ^b   Paccamiccio, Lydia ^c   Mariani, Paolo ^c   Contado, Catia ^a   Stellin, Elisa ^a   Menegatti, Enea ^a   Bonina, Francesco ^d   Puglia, Carmelo ^d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BAYREUTH   (Germany)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cryo TEM; Cubosomes; Reflectance spectroscopy; Tape stripping; X ray

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBOMER; GLYCEROL OLEATE; INDOMETACIN; POLOXAMER; WATER;

ADULT; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; EMULSION; FEMALE; FIELD FLOW FRACTIONATION; GEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; MALE; MORPHOLOGY; NORMAL HUMAN; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; REFLECTOMETRY; SKIN ABSORPTION; SPECTROPHOTOMETRY; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; X RAY DIFFRACTION;

ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYOELECTRON MICROSCOPY; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ERYTHEMA; FEMALE; FRACTIONATION, FIELD FLOW; GLYCERIDES; HUMANS; INDOMETHACIN; MALE; PARTICLE SIZE; RADIATION INJURIES; SKIN; SKIN ABSORPTION; SOLUBILITY; ULTRACENTRIFUGATION; ULTRAVIOLET RAYS; VISCOSITY; X-RAY DIFFRACTION;

EID: 29244477169     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-005-8176-x     Document Type: Article

References (43)

1. S. T. Hyde S. Andersson B. Ericsson K. Larsson 1984 A cubic structure consisting of a lipid bilayer forming an infinite periodic minimal surface of the gyroid type in the glycerol monooleate water system Z. Kristallogr. 168 213 219
2. P. Mariani V. Luzzati H. Delacroix 1988 Cubic phases of lipid-containing systems. Structure analysis and biological implications J. Mol. Biol. 204 165 189
3. V. Luzzati R. Vargas P. Mariani A. Gulik H. Delacroix 1993 Cubic phases of lipid-containing systems. Elements of a theory and biological connotations J. Mol. Biol. 229 540 551
4. H. Chung M. Caffrey 1994 The neutral area surface of the cubic mesophases: location and properties Biophys. J. 66 377 381
5. P. D'Antona W. O. Parker Jr. M. C. Zanirato E. Esposito C. Nastruzzi 2000 Rheologic and NMR characterization of monoglyceride-based formulation J. Biomed. Mater. Pharm. 52 40 52
6. S. Engstroem T. P. Norden H. Nyquist 1999 Cubic phases for studies of drug partition into lipid bilayers Eur. J. Pharm. 8 243 254
7. S. Engstroem L. Lindahl R. Wallin J. Engblom 1992 A study ofpolar lipid drug carrier systems undergoing a thermoreversible lamellar-to-cubic phase transition Int. J. Pharm. 86 137 145
8. J. C. Shah Y. Sadhale D. M. Chilukuri 2001 Cubic phase gels asdrug delivery systems Adv. Drug Deliv. Rev. 47 229 250
9. K. Larsson 2000 Aqueous dispersion of cubic lipid-water phases Curr. Opin. Colloid Interface Sci. 5 64 69
10. T. Landh and K. Larsson. Particles, method of preparing said particles and uses thereof. US patent no. 5531925 (1996).
11. J. Gustafsson H. Ljusberg-Wharen M. Almgrem K. Larsson 1997 Submicronparticles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer Langmuir 13 6964 6971
12. B. Siekmann H. Bunjes M. H. J. Koch K. Westesen 2002 Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases Int. J. Pharm. 244 33 43
13. J. S. Kim H. K. Kim H. Chung Y. T. Sohn I. C. Kwon S. Y. Jeong 2000 Drug formulations that form a dispersed cubic phase when mixed with water Proc. Int. Symp. Control. Release Bioact. Mater. 27 1118 1119
14. P. T. Spicer K. L. Hayden 2001 Novel process for producing cubic liquid crystalline nanoparticles (cubosomes) Langmuir 17 5748 5756
15. J. Gustafsson H. Ljusberg-Wharen M. Almgrem K. Larsson 1996 Cubic lipid-water phase dispersed into submicron particles Langmuir 12 4611 4613
16. E. Esposito, N. Eblovi, S. Rasi, M. Drechsler, G. M. Di Gregorio, E. Menegatti, R. Cortesi. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci. 5(4) article 30 (2003).
17. N. Lars A.-A. Ashraf 2004 Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model J. Invest. Dermatol. 4 715 732
18. 13C NMR investigation on the internal structure of "cubosomes" Langmuir 17 3917 3922
19. M. Almgrem K. Edwards G. Karlsson 2000 Cryo transmission electron microscopy of liposomes and related structures Colloids Surf., A 174 3 21
20. S. Engstrom B. Ericsson T. Landh 1996 A cubosome formulation for intravenous administration of somatostatin Proc. Int. Symp. Control. Release Bioact. Mater. 23 382 383
21. J. S. Kim H. K. Kim H. Chung Y. T. Sohn I. C. Kwon S. Y. Jeong 2000 Drug formulations that form a dispersed cubic phase when mixed with water Proc. Int. Symp. Control. Release Bioact. Mater. 27 1118 1119
22. J. B. Boyd 2000 Characterisation of drug release from cubosomes using the pressure ultrafiltration method Int. J. Pharm. 260 239 247
23. K. C. Kwan G. O. Breault E. R. Umbenhauer F. G. [tmp] McMahon D. E. Duggan 1976 Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man J. Pharm. Biopharm. 4 255 280
24. L. Helleberg 1981 Clinical pharmacokinetics of indomethacin Clin. Pharmacokinet. 6 245 258
25. P. Srinath M. G. Chary S. P. Vyas P. V. Diwan 2000 Long circulating liposomes of indomethacin in arthritic rats-a biodisposition study Pharm. Acta Helv. 74 399 404
26. C. Puglia D. Trombetta V. Venuti A. Saija F. Bonina 2004 Evaluation of in vitro topical anti-inflammatory activity of indomethacin from liposomal vesicles J. Pharm. Pharmacol. 56 1225 1232
27. S. Miyazaki A. Takahashi W. Kubo J. Bachynsky R. Lobenberg 2003 Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration J. Pharm. Pharm. Sci. 6 238 245
28. M. H. Moon I. Park Y. Kim 1998 Size characterization of liposomes by flow field-flow fractionation and photon correlation spectroscopy. Effect of ionic strength and pH of carrier solutions J. Chromatogr., A 813 91 100
29. C. Contado F. Dondi 2001 Barley starch granules subject to SPLITT cell fractionation and Sd/StFFF size characterization Starch 53 414 423
30. S. Liu M. Kamijo T. Takayasu S. Takayama 2002 Direct analysis of indomethacin in rat plasma using a column-switching high-performance liquid chromatographic system J. Chromatogr., B 767 53 60
31. R. L. Bronaugh R. F. Stewart M. Simon 1986 Methods for in vitro percutaneous absorption studies VII: use of excised human skin J. Pharm. Sci. 75 1094 1097
32. M. Bouclier A. Chatelus C. N. Hensby 1989 In vivo animal models for the evaluation of anti-inflammatory drug action in the skin N.J. Lowe C.N. Hensby Nonsteroidal Anti-inflammatory Drugs Karger Basel 118 132
33. E. Touitou B. Fabin 1988 Altered skin permeation of a highly lipophilic molecule: tetrahydrocannabinol Int. J. Pharm. 43 17 22
34. M. Ricci C. Puglia F. Bonina C. Di Giovanni S. Giovagnoli C. Rossi 2005 Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies J. Pharm. Sci. 94 1149 1159
35. A. Saija A. Tomaino D. Trombetta A. De Pasquale N. Uccella T. Barbuzzi D. Paolino F. Bonina 2000 In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents Int. J. Pharm. 199 39 47
36. J. B. Dawson D. J. Barker D. J. Ellis E. Grassam J. A. Catterill G. W. Fischer J. W. Feather 1980 A theoretical and experimental study of light absorption and scattering by in vivo skin Phys. Med. Biol. 25 696 709
37. G. Wörle, K. Westesen, M. H. J. Koch. Investigation of the phase behavior of monoolein/surfactant dispersions of different composition and preparation methods. EMBL Hamburg Outstation Annual Report (2000).
38. M. Schimpf K. Caldwell J. C. Giddings 2000 Field-Flow Fractionation Handbook Wiley-Interscience New York
39. S. Levin E. Klausner 1995 Measurements of size distribution and density of pharmaceutical fat emulsions, using field-programmed sedimentation field-flow fractionation (SdFFF) Pharm. Res. 12 1218 1224
40. S. Levin R. Nudelman P. Reschiglian L. Pasti 1995 Simulation of fractograms of fat emulsions in power-programmed sedimentation field-flow fractionation (SdFFF) J. Pharm. Biomed. Anal. 13 869 877
41. G. Lu H. W. Jun 1998 Diffusion studies of methotrexate in carbopol and poloxamer gels Int. J. Pharm. 160 1 9
42. J. J. van de Sandt J. A. van Burgsteden S. Cage P. L. Carmichael I. Dick S. Kenyon G. Korinth F. Larese J. C. Limasset W. J. Maas L. Montomoli J. B. Nielsen J. P. Payan E. Robinson P. Sartorelli K. H. Schaller S. C. Wilkinson F. M. Williams 2004 In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study Regul. Toxicol. Pharmacol. 39 271 281
43. F. P. Bonina C. Puglia T. Barbuzzi P. de Caprariis F. Palagiano M. G. Rimoli A. Saija 2001 In vitro and in vivo evaluation ofpolyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac Eur. J. Pharm. Sci. 14 123 134